Torben Arvid Kruse

Torben Arvid Kruse is a Professor at the Department of Clinical Research, University of Southern Denmark. He is affiliated with the Research Unit of Clinical Genetics (Odense) and has an active role in multidisciplinary research collaborations, including KI (Karolinska Institute) and OUH (Odense University Hospital).

• Academic Rank: Professor
• Primary Research Areas: Genetics, Genomics, Breast Cancer, Neoplasm, Cardiovascular Disease

His research focuses on genetic risk factors in diseases like breast cancer and cardiovascular conditions, with notable work on BRCA1/BRCA2 mutations and JAK2 V617F somatic mutations. Recent projects include multiomic profiling of glioblastomas and circulating tumor DNA detection in ovarian cancer.

The University of Southern Denmark serves as his primary affiliation, though his work extends to collaborative networks in health sciences. Publications span peer-reviewed journals such as Circulation, Neuro-Oncology, and Breast Cancer Research, emphasizing translational approaches linking genomics to clinical outcomes.

Scientific contributions include:

• Key roles in the DALIAH Trial comparing interferon-α and hydroxyurea for myeloproliferative neoplasms.
• Leadership in the MESTAR Study on metastatic breast cancer diagnostics.
• Media engagement on genomic research, including coverage in Wikipedia and X (Twitter) discussions.